Category «Uncategorized»

Sacubitril

Sacubitril, AHU 377 NEPRILYSIN INHIBITOR FOR HEART FAILURE CAS 149709-62-6 CAS SODIUM SALT 149690-05-1 (2R,4S)-5-(biphenyl-4-yl)-4-((3-carboxypropionyl)amino)-2-methylpentanoic acid ethyl ester 5-(Biphenyl-4-yl)-4(S)-(3-carboxypropionamido)-2(R)-methylbutyric acid ethyl ester N-(3-carboxy-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-2R-methyl butanoic acid ethyl ester [1,1′-Biphenyl]-4-pentanoic acid, γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-, α-ethyl ester, (αR,γS)- [1,1′-Biphenyl]-4-pentanoic acid, γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-, ethyl ester, [S-(R*,S*)]- (2R,4S)-4-[(3-Carboxy-1-oxopropyl)amino]-4-[(p-phenylphenyl)methyl]-2-methylbutanoic acid ethyl ester (2R,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester Formula C24H29NO5 MW 411.49 g/mol AHU377; AHU-377; Sacubitril; 149709-62-6; …

VALSARTAN

VALSARTAN CAS 137862-53-4 Molecular FormulaC24H29N5O3, Average mass435.519 Da (2S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid PAPER Greening the Valsartan Synthesis: Scale-up of Key Suzuki–Miyaura Coupling over SiliaCat DPP-Pd Valerica Pandarus †, Delphine Desplantier-Giscard†, Geneviève Gingras , François Béland †*, Rosaria Ciriminna ‡, and Mario Pagliaro ‡* † SiliCycle Inc., 2500 Parc-Technologique Blvd, Quebec City, Quebec, Canada G1P 4S6 ‡ Istituto per lo Studio dei Materiali Nanostrutturati, CNR, via U. La Malfa 153, 90146 …

Idasanutlin, RG-7388, идасанутлин ,إيداسانوتلين , 依达奴林

Idasanutlin(RG-7388) cas     1229705-06-9 идасанутлин [Russian] إيداسانوتلين [Arabic] 依达奴林 [Chinese] 4-{ [(2R,3S,4R,5S)-4-(4-Chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2- dimethyl-prop yl)-pyrrolidine-2-carbonyl] -amino }-3-methoxy-benzoic acid (C31H29Cl2F2N304) 4-{[(2R,3S,4R,5S)-4-(4-Chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic acid MW 616.4973 F. Hoffmann-La Roche Ag, Hoffmann-La Roche Inc.ROCHE PHASE1 for the oral treatment of cancer, including solid tumors and hematological tumors, including acute myelogenous leukemia Acute myelogenous leukemia; Cancer; Prostate tumor Mdm2 p53-binding protein inhibitor …

SUGAMMADEX (Org 25969, Bridion)

SUGAMMADEX CAS number 343306-71-8 Weight Average: 2002.12 Monoisotopic: 2000.408874758 Chemical Formula C72H112O48S8 WATCH OUT POST WILL BE UPDATED……… SUGAMMADEX 343306-71-8 cas  free Sugammadex sodium 343306-79-6 MF: C72H104O48S8.8Na MW: 2178.01 Bridion; UNII-ERJ6X2MXV7; Suγdex Sodium; Suγdex; 343306-79-6; Org 25969; Sugammadex, Org25969; Org-25969; Org 25969; 361LPM2T56 Sugammadex (Org 25969, Bridion) is chemically known as Cyclooctakis-(l-→4)-[6-S-(2-carboxyethyl)-6-thio-a-D-glucopyranosyl]. Sugammadex sodium, 343306-79-6 CAS No.:343306-71-8 free Molecular …

ACS INDUSTRY SYMPOSIUM , RECENT ADVANCES IN DRUG DEVELOPMENT HYDERABAD, INDIA, Dr. REDDYS, Nov 11-12 2016

GROUP PICTURE Inaugural ACS Industry Symposium, 11-12 November 2016 in Hyderabad, India Recent Advances in Drug Development ACS2016 ACS Symposium at Dr. Reddy’s Hyderabad, India, Nov 11-12 2016 ACS INDUSTRY SYMPOSIUM , RECENT ADVANCES IN DRUG DEVELOPMENT HYDERABAD, INDIA, http://acssymposium.org.in/  The American Chemical Society (ACS) hosted the inaugural ACS Industry Symposium at Dr. Reddy’s Laboratories in …

Acetylcholine Chloride

Acetylcholine Chloride 2-acetyloxyethyl(trimethyl)azanium;chloride 60-31-1 Molecular Formula: C7H16ClNO2 Molecular Weight: 181.66 g/mol Acetylcholine chloride is obtained as white or off-white hygroscopic crystals, or as a crystalline powder. The salt is odorless, or nearly odorless, and is a very deliquescent powder. Acetylcholine bromide is obtained as deliquescent crystals, or as a white crystalline powder. The substance is …

Valdetamide

CAS Registry Number: 512-48-1 CAS Name: 2,2-Diethyl-4-pentenamide Additional Names: diethylallylacetamide Trademarks: Novonal (Hoechst) Molecular Formula: C9H17NO Molecular Weight: 155.24 Percent Composition: C 69.63%, H 11.04%, N 9.02%, O 10.31% Literature References: Description: Bockmühl, Schaumann, Dtsch. Med. Wochenschr. 54, 270 (1928). Pharmacokinetics and metabolism: H. Uehleke, M. Brinkschulte-Freitas, Arch. Pharmacol. 302, 11 (1978). TLC determn in urine: E. Klug, P. Toffel, Arzneim.-Forsch. 29, 1651 (1979). Properties: White powder, mp 75-76°. Sol in 120 parts …